2022 COCA Calls/Webinars Information, Summaries, & Slide Sets
Title: Monkeypox: Updates about Clinical Diagnosis and Treatment
Date: Wednesday, June 29, 2022
Presenters:
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Leandro A. Mena, MD, MPH, FIDSA
Director, Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
Brett Petersen, MD, MPH
CAPT, U.S. Public Health Service
Deputy Chief, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Date: Wednesday, June 22, 2022
Presenters:
Sara Oliver, MD, MSPH
CDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
Chief Medical Officer, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Clinical Guidelines Lead
Chief Medical Officer, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Kevin Chatham-Stephens, MD, MPH
CDR, U.S. Public Health Service
Pediatric Vaccine Planning and Implementation Lead
Vaccine Coordination Unit
COVID-19 Response
Centers for Disease Control and Prevention
Anne M. Hause, PhD, MSPH
v-safe Team Co-lead, Immunization Safety Office
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Title: What Clinicians Need to Know About Available Therapeutic Options for COVID-19
Date: Thursday, June 16, 2022
Presenters:
Pragna Patel, MD, MPH
Chief Medical Officer, COVID-19 Response
Centers for Disease Control and Prevention
Eric Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Clinical Guidelines Team
National Institutes of Health
John Farley, MD, MPH
Director, Office of Infectious Diseases
Office of New Drugs, Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Meg Sullivan, MD, MPH, FAAP
Chief Medical Officer
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services
Title: What Clinicians Need to Know about Monkeypox in the United States and Other Countries
Date: Tuesday, May 24, 2022
Presenters:
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Laura Hinkle Bachmann, MD, MPH, FIDSA, FACP
Chief Medical Officer
Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Control
Centers for Disease Control and Prevention
Brett Petersen, MD, MPH
CAPT, U.S. Public Health Service
Deputy Chief, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Date: Thursday, May 19, 2022
Presenters:
L. Amanda Ingram, MPH
Epidemiologist Supervisor
Infectious Diseases & Outbreaks Division
Alabama Department of Public Health
Jacqueline Tate, PhD
Epidemiology Team Lead, Viral Gastroenteritis Branch
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Helena Gutierrez, MD
Medical Director, Pediatric Liver Transplant Program
Assistant Professor, Division of Pediatric Gastroenterology, Hepatology, and Nutrition
The University of Alabama at Birmingham
Elizabeth A. Moulton, MD, PhD
Assistant Professor of Pediatrics
Transplant Infectious Diseases
Baylor College of Medicine
Texas Children’s Hospital
Title: Updated Guidance for Clinicians on COVID-19 Vaccines
Date: Thursday, May 5, 2022
Presenters:
Jennifer Cope, MD, MPH
Medical Officer
Post-COVID Conditions Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Michelle Haddad, PhD
Director of Post-COVID Neuropsychology Clinic
Director of Inpatient Neuropsychology
Departments of Rehabilitation Medicine & Neurology
Emory University School of Medicine
Jeffrey S. Fine, MD, FAAPMR
Associate Professor and Vice Chair, Rusk Rehabilitation
Dept of Rehabilitation Medicine and Dept of Medicine
NYU Langone Health
Talya K. Fleming, MD
Assistant Professor and Medical Director
JFK Johnson Rehabilitation Institute
Dept of Physical Medicine and Rehabilitation
Hackensack Meridian Medicine
Title: Updated Guidance for Clinicians on COVID-19 Vaccines
Date: Thursday, February 24, 2022
Presenters:
Sara Oliver, MD MSPH
LCDR, U.S. Public Health Service
Lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Evelyn Twentyman, MD, MPH
Chief Medical Officer, Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Title: COVID-19 Updates: What Clinicians Need to Know About Multisystem Inflammatory Syndrome in Children
Date: Thursday, February 10, 2022
Presenters:
Angela Campbell, MD, MPH, FAAP, FPIDS, FIDSA
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention
Shana Godfred-Cato, DO, FAAP
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention
Anna Yousaf, MD
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention
Date: Thursday, January 13, 2022
Presenters:
Lauri Hicks, DO
Captain, U.S. Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Alexander Kallen, MD, MPH
Chief, Prevention and Response Branch
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Pragna Patel, MD, MPH
Deputy Principal Incident Manager, COVID-19 Response
Senior Medical and Science Advisor, HIV Prevention Branch
Division of Global HIV and TB
Centers for Disease Control and Prevention
Title: What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19
Date: Wednesday, January 12, 2022
Presenters:
Lauri Hicks, DO
Captain, US Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention
Stephanie Troy, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Aimee Hodowanec, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Alice K. Pau, PharmD
Executive Secretary, NIH COVID-19 Treatment Guidelines Panel
Staff Scientist (Clinical)
Clinical Pharmacy Specialist
Division of Clinical Research
National Institute of Allergy & Infectious Diseases
National Institutes of Health